课题基金 / 基金详情

PYRIMIDINE NUCLEOSIDE PHOSPHORYLASES IN CHEMOTHERAPY

PYRIMIDINE NUCLEOSIDE PHOSPHORYLASES IN CHEMOTHERAPY
嘧啶核苷磷酸化酶在化疗中的应用
批准号:
3178382
负责人:
SHIH-HSI CHU
金额:
$14.05万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
1985
资助国家:
美国
项目状态:
已结题
起止时间:
1985-09-01 至 1992-11-30

项目摘要

项目成果

SHIH-HSI CHU的其他基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
The objectives of this grant proposal are: 1. Chemical synthesis of analogs and derivatives of BAU (5-benzylacyclouridine) and BBAU (5-benzyloxybenzylacyclouridine), potent inhibitors of uridine phosphorylase and potentiators of the anti-tumor action of FUdR, designed to improve facility of clinical use, to produce new anti-tumor drugs and pro-drugs, and to explore further their biological properties. 2. Biological testing of these new agents as inhibitors of uridine phosphorylase and, where indicated, thymidine phosphorylase, as transport inhibitors, anti-tumor agents and potentiators both in vitro and in vivo, and as tools for obtaining new biochemical knowledge related to nucleic acid metabolism. These studies will be performed in collaboration with colleagues in the Roger Williams Cancer Center.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
CORE--MEDICINAL CHEMISTRY
  • 批准号:
    3751846
  • 项目类别:
  • 资助金额:
    $0.0万
  • 财政年份:
    --
  • 负责人:
    SHIH-HSI CHU
  • 依托单位:
CORE--MEDICINAL CHEMISTRY
  • 批准号:
    3774176
  • 项目类别:
  • 资助金额:
    $0.0万
  • 财政年份:
    --
  • 负责人:
    SHIH-HSI CHU
  • 依托单位: